Onesource Specialty Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP
EarningsCanvas
Loading your research…
Opening the latest published company and exchange records.
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
An exchange could not be refreshed. These are last known disclosures. Check the official exchange for newer announcements.
Onesource Specialty Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP
Onesource Specialty Pharma Limited has informed the Exchange about change in Management
Onesource Specialty Pharma Limited has informed the Exchange about the Participation in Jefferies Global Healthcare Conference to be held from November 16, 2026 to November 19, 2026 in London.
Onesource Specialty Pharma Limited has given an intimation of Transcript of Earnings call dated October 27, 2026
Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated October 30, 2026, titled "OneSource Receives USFDA EIR with VAI Classification, Marking Completion of Inspection Process at its Sterile Product Division (SPD) Facility in Bengaluru".
Onesource Specialty Pharma Limited has informed the Exchange about Copy of Newspaper Publication - Extract of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026
Onesource Specialty Pharma Limited has informed the Exchange about Link of Recording
Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "OneSource Announces Strong Q2FY27 ResultsRevenue up 37% YoY and EBITDA up 53% YoY".
Onesource Specialty Pharma Limited has informed the Exchange regarding 'Allotment of 360 Equity Shares of INR. 1/- each, under ONESOURCE ESOP 2021'.
Onesource Specialty Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.
Onesource Specialty Pharma Limited has submitted to the Exchange, the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026.